Searched for
SPECIALITY CHEMICALS IPO
Prasol Chemicals IPO Day 2: GMP, subscription status. Should you subscribe?The Prasol Chemicals IPO entered Day 2 of bidding after garnering 41% subscription on the first day. Priced at Rs 643–676 per share, the Rs...- Prasol Chemicals IPO opens for bidding. Check GMP and other key detailsThe Prasol Chemicals IPO opened for subscription on September 8 and will remain open until September 10. The Rs 500 crore issue comprises a...
- Prasol Chemicals mobilises Rs 150 cr from anchor investors ahead of IPOPrasol Chemicals has raised nearly Rs 150 crore from anchor investors ahead of its Rs 500-crore IPO, which opens on September 8. The specia...
- Reliance shares are down 17% despite soaring refining margins. What the market is missingDespite strong refining and petrochemical margins, Reliance shares have experienced a dip as the market focuses on long-term growth potenti...
- Corporate actions this week: NTPC, Coal India among nearly 90 cos set to hit record dates for dividend payouts, bonus issues & stock splitsNearly 90 companies, including NTPC, Coal India and Oil India, have scheduled record dates for dividends, bonus issues and stock splits fro...
- These 19 Indian stocks turned into tenbaggers in 5 years: Peter Lynch’s rules to find the nextOver the last five years, various Indian stocks have reached extraordinary tenbagger returns, including remarkable surges in GE Vernova T&D...
- Investors are watching Jio but Mukesh Ambani-led RIL’s Q1 surprise may come from refiningReliance Industries' upcoming first-quarter earnings may depend on refining gains. Jio's steady expansion is expected to provide a stable g...
- Balaji Amines arm Balaji Speciality Chemicals withdraws IPO papers"In connection with the offer, we have been informed by the BSCL that its Board of Directors through a resolution passed in the Board Meeti...
- IPO Rush! 10 public offers may hit primary market to raise Rs 8,000 cr in AugustFor more such web stories click on the ET
- Balaji Amines arm files DRHP with Sebi for IPOBalaji Speciality Chemicals manufactures niche chemicals such as ethylene diamine, piperazine anhydrous, diethylenetriamine, aminoethyl eth...
- Ami Organics needs to prove its case among a wide menu of optionsAmi Organics has developed and commercialised 450 intermediates for active ingredients in 17 key therapeutic areas, and supplies to 150 com...
- Speciality chem firm Clean Science and Tech planning Rs 1,400 cr IPOAxis Capital, JM Financial and Kotak Mahindra Capital company are likely to lead the issue as merchant bankers.
- Chemcon Specialty Chemicals IPO subscribed 149 times; grey market premium rises to 88%The Vadodara-based company plans to raise Rs 318 crore, out of which it already raised Rs 95.40 crore through allotment of 28.06 lakh share...
- Chemcon Speciality IPO subscribed 12.65 times; retail portion filled in 23 timesChemcon Speciality Chemicals IPO will fetch Rs 318 crore at the upper end of the price band. Bidding closes tomorrow.
- Investors may wait for clear business trends in ChemconThe Vadodara-based company plans to raise ₹318 crore from the initial public offering (IPO), out of which ₹153 crore is an offer for sale b...
- Chemcon Speciality IPO: Issue size, price band & other key detailsThe firm is India’s largest manufacturer of specialised chemicals, such as Hexamethyldisilazane / Hexamethyldisilane (HMDS) and Chloromethy...
- EaseMyTrip, Puranik Builders & 2 others get nod for IPOEaseMyTrip.com plans to float a Rs 510 crore initial public offering (IPO).
- Neogen Chemicals IPO set to open: Why are some analysts giving it ‘avoid’ ratingOne may subscribe to the IPO with a long-term horizon or give it a miss, many analysts said.
- Omkar Speciality disappoints on debut, plunges 40 pc on BSEMaking a disastrous debut on the bourses, Omkar Speciality Chemicals nosedived by nearly 40% from its issue price of Rs 98 on BSE.
- Omkar Speciality IPO looks expensive:SPA SecuritiesSPA Securities is of the view that the initial public offering of Omkar Speciality Chemicals looks expensive as compared to peers.
Load More
